Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls

Wiener klinische Wochenschrift
Christiane ThallingerChristoph Zielinski

Abstract

Immunotherapy by checkpoint inhibition is about to profoundly change cancer therapy. The number of indications are growing at an unprecedented speed. Clinical studies have demonstrated efficacy in a variety of solid tumors and in hematologic malignancies, although some clinical trials have produced negative results. Thus, it is fair to assume that there are obvious limitations and pitfalls in immunotherapy. Future concepts for combination treatment of immune checkpoint inhibitors have to be developed, but there is also urgent need for better and standardized biomarkers to identify those cancer patients who will benefit from treatment by checkpoint inhibition. The current overview summarizes current knowledge on immune checkpoint inhibitor treatment in malignancies, its outlook and limitations, diagnostic means and, finally, side effect management.

References

Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
Jan 13, 2015·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C ThallingerC Zielinski
Feb 2, 2015·Clinical Therapeutics·Jovan MihajlovićMaarten J Postma
Feb 11, 2015·The Journal of International Medical Research·Cheng ChenHanbo Le
Apr 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Inge C van GoolDavid N Church
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
May 16, 2015·Cancer Research·Michele W L TengMark J Smyth
Oct 20, 2015·Seminars in Oncology·Edward B Garon
Oct 31, 2015·Science·Erika VacchelliGuido Kroemer
Jan 15, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M MichotO Lambotte
Mar 1, 2016·Advances in Immunology·Matthew D HellmannJedd D Wolchok
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philippe ArmandCraig H Moskowitz
Jul 2, 2016·JAMA Oncology·Claire F FriedmanMichael A Postow
Jul 19, 2016·Expert Review of Clinical Immunology·Kathryn E BeckermannJeffrey A Sosman
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Swati KhannaRaffit Hassan
Sep 14, 2016·Expert Review of Hematology·Pamela Blair Allen, Leo I Gordon
Dec 3, 2016·Gynecologic Oncology Research and Practice·Stéphanie L GaillardBradley Monk
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C F Friedman, A Snyder
Dec 21, 2016·Nature Reviews. Clinical Oncology·Saskia LitièreJan Bogaerts
Dec 30, 2016·Cancer Discovery·Valsamo AnagnostouVictor E Velculescu
Jan 18, 2017·Nature Reviews. Clinical Oncology·Ralph R WeichselbaumYang-Xin Fu
Jan 21, 2017·Journal for Immunotherapy of Cancer·Kathryn E BeckermannDouglas B Johnson
Feb 12, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F LordickY Y Janjigian
Feb 18, 2017·The New England Journal of Medicine·Guru Sonpavde
Mar 8, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Kandolf SekulovicC Garbe
Mar 9, 2017·The Lancet Oncology·Lesley SeymourUNKNOWN RECIST working group
Mar 24, 2017·OncoTargets and Therapy·Ahmet Murat AydinLaura-Maria Krabbe
Apr 6, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G Friberg, D Reese
May 13, 2017·OncoTargets and Therapy·Cristina IlcusMihnea Zdrenghea
Jun 28, 2017·Immunotherapy·Andrew W HahnNeeraj Agarwal
Jul 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans J HammersAsim Amin
Jul 12, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bhargavi PulluriSrinath Sundararajan
Jul 18, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nadya DimitrovaUNKNOWN SEE+ Working Group
Jul 28, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bo Hwa SohnJu-Seog Lee

❮ Previous
Next ❯

Citations

Apr 3, 2019·Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale·M C MerlanoO Garrone
May 5, 2020·Expert Opinion on Drug Discovery·Blaise Calpe, Werner J Kovacs
Aug 16, 2019·Physiological Reviews·Carla Riera-DomingoMassimiliano Mazzone
Jul 1, 2020·Luminescence : the Journal of Biological and Chemical Luminescence·Lan WangJunzhi Wang
Jul 10, 2018·Memo·Lucian BeerHelmut Prosch
May 21, 2020·Wiener klinische Wochenschrift·Lucian BeerHelmut Prosch
Dec 21, 2017·International Journal of Molecular Sciences·Ali S ArbabBhagelu R Achyut
Jun 15, 2019·International Journal of Clinical Oncology·Stylianos VagiosKitty Pavlakis
May 12, 2019·Proceedings of the National Academy of Sciences of the United States of America·Alexander Levitzki, Shoshana Klein
Apr 5, 2020·Cancers·Michael F ColemanStephen D Hursting
May 10, 2018·Journal of Cutaneous Pathology·B Joel TjarksJonathan S Bleeker
Aug 10, 2018·Experimental & Molecular Medicine·Yunsik ChoiCharles Lee
May 20, 2020·Journal of Experimental & Clinical Cancer Research : CR·Filippo GalliAlberto Signore
Jul 2, 2020·Pharmaceutics·Sara ZalbaMaría Jesús Garrido
Aug 1, 2019·Journal for Immunotherapy of Cancer·Thuy T TranHarriet M Kluger
Oct 13, 2020·Expert Opinion on Investigational Drugs·Si-Yang Liu, Yi-Long Wu
Oct 18, 2020·International Journal of Molecular Sciences·Aristofania SimatouMichalis V Karamouzis
Dec 2, 2020·International Journal of Molecular Sciences·Huang-Yu YangTao-Han Lee
Aug 7, 2019·Life Sciences·Humera Memon, Bhoomika M Patel
Mar 2, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhuoxuan LuLiming Zhang
Feb 22, 2021·The Ocular Surface·Royce B ParkJennifer Park
Apr 8, 2021·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Neeraj Chhabra, Joseph Kennedy
Apr 19, 2021·Journal of Nanobiotechnology·Rafieh BagherifarYousef Javadzadeh
Apr 29, 2021·Macromolecular Bioscience·Ai Lin ChinRong Tong
Jul 1, 2021·Medical Oncology·Seda KahramanBulent Yalcin
Aug 29, 2018·ACS Infectious Diseases·Michael PhanJean-Simon Diallo
Aug 24, 2021·Current Opinion in Biomedical Engineering·Luman LiuBalaji Narasimhan
Aug 28, 2021·Cells·Sandra CasimiroLuis Costa
Sep 4, 2021·Journal of Cancer Research and Clinical Oncology·Santosh A HelekarMartyn A Sharpe
Sep 22, 2021·Journal of Gastroenterology and Hepatology·Sadie De SilvaTrilokesh D Kidambi
Oct 13, 2021·Journal for Immunotherapy of Cancer·Briana Rose HalleVeronica M Rotemberg
Jul 2, 2019·Asia-Pacific Journal of Oncology Nursing·Fedricker Diane Barber
Oct 5, 2021·Annual Review of Medicine·Rubens Copia SperandioAhmed O Kaseb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Current Opinion in Urology
Max M WattenbergJames L Gulley
The Lancet Oncology
Lysanne A LievenseJoachim G Aerts
Gan to kagaku ryoho. Cancer & chemotherapy
Fumie Ihara, Shinichiro Motohashi
Current Oncology Reports
Brenda Ernst, Karen S Anderson
© 2022 Meta ULC. All rights reserved